Abstract
Gallbladder cancer, though generally considered rare, is the most common malignancy of the biliary tract, accounting for 80−95 % of biliary tract cancers. An early diagnosis is essential as this malignancy progresses silently with a late diagnosis, often proving fatal. Surgery represents the only potential for cure. Some individuals are fortunate to be incidentally found to have gallbladder cancer at the time of cholecystectomy being performed for cholelithiasis. Such an early diagnosis is imperative as a late presentation connotes advanced staging, nodal involvement, and possible recurrence following attempted resection.
Overall mean survival is a mere 6 months, while 5-year survival rate is only 5 %. The dismal prognosis, in part, relates to the gallbladder lacking a serosal layer adjacent to the liver, enabling hepatic invasion and metastatic progression. Improved imaging modalities are helping to diagnose patients at an earlier stage. The last decade has witnessed improved outcomes as aggressive surgical management and preoperative adjuvant therapy has helped prolong survival in patients with gallbladder cancer.
In the future, the development of potential diagnostic markers for disease will yield screening opportunities for those at risk either with ethnic susceptibility or known anatomic anomalies of the biliary tract. Meanwhile, clarification of the value of prophylactic cholecystectomy should provide an opportunity for secondary prevention. Primary prevention will arrive once the predictive biomarkers and environmental risk factors are more clearly identified.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Agarwal AK, Kalayarasan R, Javed A et al (2013) The role of staging laparoscopy in primary gall bladder cancer–an analysis of 409 patients: a prospective study to evaluate the role of staging laparoscopy in the management of gallbladder cancer. Ann Surg 258:318
Anderson CD, Rice MH, Pinson CW et al (2004) Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma. J Gastrointest Surg 8:90
Ansari MA, Tiwary SK, Shahi UP, Shukla VK (2014) Role of combination chemotherapy with 5-fluorouracil, cisplatin and paclitaxel for advanced gall bladder cancer. J Cancer Ther 5:246–252
Antonakis P, Alexakis N, Mylonaki D et al (2003) Incidental finding of gallbladder carcinoma detected during or after laparoscopic cholecystectomy. Eur J Surg Oncol 29:358
Bartlett DL (2000) Gallbladder cancer. Semin Surg Oncol 19:145
Bartlett DL, Fong Y, Fortner JG et al (1996) Long-term results after resection for gallbladder cancer. Implications for staging and management. Ann Surg 224:639
Ben-David MA, Griffith KA, Abu-Isa E et al (2006) External-beam radiotherapy for localized extrahepatic cholangiocarcinoma. Int J Radiat Oncol Biol Phys 66:772
Benson AB 3rd, D’Angelica MI, Abrams TA et al (2014) Hepato-biliary cancers, version 2.2014. J Natl Compr Canc Netw 12(8):1152–1182
Blumgart LH (2007) Surgery of the liver, biliary tract and pancreas, 4th edn. Saunders, Philadelphia
Busse PM, Cady B, Bothe A Jr et al (1991) Intraoperative radiation therapy for carcinoma of the gallbladder. World J Surg 15:352
Butte JM, Gönen M, Allen PJ et al (2011) The role of laparoscopic staging in patients with incidental gallbladder cancer. HPB (Oxford) 13:463
Cavallaro A, Piccolo G, Panebianco V et al (2012) Incidental gallbladder cancer during laparoscopic cholecystectomy: managing an unexpected finding. World J Gastroenterol 18:4019
Chijiiwa K, Noshiro H, Nakano K et al (2000) Role of surgery for gallbladder carcinoma with special reference to lymph node metastasis and stage using western and Japanese classification systems. World J Surg 24:1271
Cho SY, Kim SH, Park SJ et al (2010) Adjuvant chemoradiation therapy in gallbladder cancer. J Surg Oncol 102:87
Corvera CU, Blumgart LH, Akhurst T et al (2008) 18 F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancer. J Am Coll Surg 206:57
Cubertafond P, Mathonnet M, Gainant A, Launois B (1999) Radical surgery for gallbladder cancer. Results of the French surgical association survey. Hepatogastroenterology 46:1567
D’Angelica M, Dalal KM, DeMatteo RP et al (2009) Analysis of the extent of resection for adenocarcinoma of the gallbladder. Ann Surg Oncol 16:806
de Aretxabala X, Roa I, Burgos L et al (1992) Gallbladder cancer in Chile. A report on 54 potentially resectable tumors. Cancer 69:60
Donohue JH, Nagorney DM, Grant CS et al (1990) Carcinoma of the gallbladder. Does radical resection improve outcome? Arch Surg 125:237
Doval DC, Sekhon JS, Gupta SK, Fuloria J, Shukla VK, Gupta S, Awasthy BS (2004) A phase II study of gemcitabine and cisplatin in chemotherapy-naïve, unresectable gallbladder cancer. Br J Cancer 90(8):1516–1520
Duffy A, Capanu M, Abou-Alfa GK et al (2008) Gallbladder cancer (GBC): 10-year experience at Memorial Sloan- Kettering Cancer Centre (MSKCC). J Surg Oncol 98:485
Eckel F, Schmid RM (2007) Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials. Br J Cancer 96:896
Eckel F, Brunner T, Jelic S (2011) ESMO Guidelines Working Group. Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 22(Suppl 6):vi40
Edge SB, Byrd DR, Compton CC et al (eds) (2010) American Joint Committee on Cancer Staging Manual, 7th edn. Springer, New York, p 211
Endo I, Shimada H, Takimoto A et al (2004) Microscopic liver metastasis: prognostic factor for patients with pT2 gallbladder carcinoma. World J Surg 28:692
Fong Y, Heffernan N, Blumgart LH (1998) Gallbladder carcinoma discovered during laparoscopic cholecystectomy: aggressive reresection is beneficial. Cancer 83:423
Fong Y, Jarnagin W, Blumgart LH (2000) Gallbladder cancer: comparison of patients presenting initially for definitive operation with those presenting after prior noncurative intervention. Ann Surg 232:557
Foster JM, Hoshi H, Gibbs JF et al (2007) Gallbladder cancer: defining the indications for primary radical resection and radical re-resection. Ann Surg Oncol 14:833
Gallardo J, Rubio B, Villanueva L, Barajas O (2005) Gallbladder cancer, a different disease that needs individual trials. J Clin Oncol 23:7753
Gaujoux S, Allen PJ (2010) Role of staging laparoscopy in peri-pancreatic and hepatobiliary malignancy. World J Gastrointest Surg 2:283
Gebbia V, Majello E, Testa A et al (1996) Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.). Cancer 78:1300
Gebbia V, Giuliani F, Maiello E et al (2001) Treatment of inoperable and/or metastatic biliary tree carcinomas with single-agent gemcitabine or in combination with levofolinic acid and infusional fluorouracil: results of a multicenter phase II study. J Clin Oncol 19:4089
Giuliante F, Ardito F, Vellone M et al (2006) Port-sites excision for gallbladder cancer incidentally found after laparoscopic cholecystectomy. Am J Surg 191:114
Goetze TO, Paolucci V (2008) Benefits of reoperation of T2 and more advanced incidental gallbladder carcinoma: analysis of the German registry. Ann Surg 247:104
Gunderson LL, Martin JK, O’Connell MJ et al (1985) Residual, recurrent, or unresectable gastrointestinal cancer. Role of radiation in single or combined modality treatment. Cancer 55:2250
Harvey JH, Smith FP, Schein PS (1984) 5-fluorouracil, mitomycin, and doxorubicin (FAM) in carcinoma of the biliary tract. J Clin Oncol 2:1245
Ito M, Mishima Y, Sato T (1991) An anatomical study of the lymphatic drainage of the gallbladder. Surg Radiol Anat 13:89
Jarnagin WR, Ruo L, Little SA et al (2003) Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies. Cancer 98:1689
Jayaraman S, Jarnagin WR (2010) Management of gallbladder cancer. Gastroenterol Clin North Am 39:331
Kajanti M, Pyrhönen S (1994) Epirubicin-sequential methotrexate-5-fluorouracil-leucovorin treatment in advanced cancer of the extrahepatic biliary system. A phase II study. Am J Clin Oncol 17:223
Kalpathy-Cramer J, Hersh W, Kim JS et al (2008) Survival prediction models for estimating the benefit of post-operative radiation therapy for gall bladder cancer and lung cancer. AIA Annu Symp Proc 6:348–352
Kapoor VK (2001) Incidental gallbladder cancer. Am J Gastroenterol 96:627
Konstantinidis IT, Deshpande V, Genevay M et al (2009) Trends in presentation and survival for gallbladder cancer during a period of more than 4 decades: a single-institution experience. Arch Surg 144:441
Levy AD, Murakata LA, Rohrmann CA Jr (2001) Gallbladder carcinoma: radiologic-pathologic correlation. Radiographics 21:295
Lindell G, Holmin T, Ewers SB et al (2003) Extended operation with or without intraoperative (IORT) and external (EBRT) radiotherapy for gallbladder carcinoma. Hepatogastroenterology 50:310
Lubner SJ, Mahoney MR, Kolesar JL et al (2010) Report of a multicenter phase II trial testing a combination of biweekly bevacizumab and daily erlotinib in patients with unresectable biliary cancer: a phase II Consortium study. J Clin Oncol 28:3491
Malik IA, Aziz Z, Zaidi SH, Sethuraman G (2003) Gemcitabine and cisplatin is a highly effective combination chemotherapy in patients with advanced cancer of the gallbladder. Am J Clin Oncol 26:174
Matsumoto Y, Fujii H, Aoyama H et al (1992) Surgical treatment of primary carcinoma of the gallbladder based on the histologic analysis of 48 surgical specimens. Am J Surg 163:239
Mekeel KL, Hemming AW (2007) Surgical management of gallbladder carcinoma: a review. J Gastrointest Surg 11:1188
Miller G, Jarnagin WR (2008) Gallbladder carcinoma. Eur J Surg Oncol 34:306
Misra MC, Guleria S (2006) Management of cancer gallbladder found as a surprise on a resected gallbladder specimen. J Surg Oncol 93:690
Morrow CE, Sutherland DE, Florack G et al (1983) Primary gallbladder carcinoma: significance of subserosal lesions and results of aggressive surgical treatment and adjuvant chemotherapy. Surgery 94:709
Murakami Y, Uemura K, Sudo T et al (2009) Adjuvant gemcitabine plus S-1 chemotherapy improves survival after aggressive surgical resection for advanced biliary carcinoma. Ann Surg 250:950
Nakeeb A, Tran KQ, Black MJ et al (2002) Improved survival in resected biliary malignancies. Surgery 132:555
Ogura Y, Mizumoto R, Isaji S et al (1991) Radical operations for carcinoma of the gallbladder: present status in Japan. World J Surg 15:337
Ogura Y, Tabata M, Kawarada Y, Mizumoto R (1998) Effect of hepatic invasion on the choice of hepatic resection for advanced carcinoma of the gallbladder: histologic analysis of 32 surgical cases. World J Surg 22:262
Oswalt CE, Cruz AB Jr (1977) Effectiveness of chemotherapy in addition to surgery in treating carcinoma of the gallbladder. Rev Surg 34:436
Ouchi K, Suzuki M, Tominaga T et al (1994) Survival after surgery for cancer of the gallbladder. Br J Surg 81:1655
Papakostas P, Kouroussis C, Androulakis N et al (2001) First-line chemotherapy with docetaxel for unresectable or metastatic carcinoma of the biliary tract. A multicentre phase II study. Eur J Cancer 37:1833
Park BK, Paik YH, Park JY et al (2006) The clinicopathologic significance of the expression of vascular endothelial growth factor-C in intrahepatic cholangiocarcinoma. Am J Clin Oncol 29:138
Patt YZ, Hassan MM, Lozano RD et al (2001) Phase II trial of cisplatin, interferon alpha-2b, doxorubicin, and 5- fluorouracil for biliary tract cancer. Clin Cancer Res 7:3375
Patt YZ, Hassan MM, Aguayo A et al (2004) Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinoma. Cancer 101:578
Pawlik TM, Gleisner AL, Vigano L et al (2007) Incidence of finding residual disease for incidental gallbladder carcinoma: implications for re-resection. J Gastrointest Surg 11:1478
Philip PA, Mahoney MR, Allmer C et al (2006) Phase II study of erlotinib in patients with advanced biliary cancer. J Clin Oncol 24:3069
Pilgrim CH, Usatoff V, Evans P (2009) Consideration of anatomical structures relevant to the surgical strategy for managing gallbladder carcinoma. Eur J Surg Oncol 35:1131
Ramanathan RK, Belani CP, Singh DA et al (2006) Phase II study of lapatinib, a dual inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase 1 and 2 (Her2/Neu) in patients (pts) with advanced biliary tree cancer (BTC) or hepatocellular cancer (HCC) (abstract). J Clin Oncol 24:180s
Riechelmann RP, Townsley CA, Chin SN et al (2007) Expanded phase II trial of gemcitabine and capecitabine for advanced biliary cancer. Cancer 110:1307
Sancho A, Lopez-Vivanco G, Diaz de Concuera I et al (2008) Oxaliplatin and capecitabine after gemcitabine failure in patients with advanced, pancreatic, biliary, and gallbladder adenocarcinoma (APBC). J Clin Oncol 26(15):s15625
Scheingraber S, Justinger C, Stremovskaia T et al (2007) The standardized surgical approach improves outcome of gallbladder cancer. World J Surg Oncol 5:55
Sharma A, Dwary AD, Mohanti BK et al (2010) Best supportive care compared with chemotherapy for unresectable gall bladder cancer: a randomized controlled study. J Clin Oncol 28:4581
Shih SP, Schulick RD, Cameron JL et al (2007) Gallbladder cancer: the role of laparoscopy and radical resection. Ann Surg 245:893
Shimada H, Endo I, Togo S et al (1997) The role of lymph node dissection in the treatment of gallbladder carcinoma. Cancer 79:892
Shimizu Y, Ohtsuka M, Ito H et al (2004) Should the extrahepatic bile duct be resected for locally advanced gallbladder cancer? Surgery 136:1012
Shirai Y, Yoshida K, Tsukada K et al (1992) Identification of the regional lymphatic system of the gallbladder by vital staining. Br J Surg 79:659
Shoup M, Fong Y (2002) Surgical indications and extent of resection in gallbladder cancer. Surg Oncol Clin N Am 11:985
Shukla VK, Khandelwal C, Roy SK, Vaidya MP (1985) Primary carcinoma of the gallbladder: a review of a 16 year period at the university hospital. J Surg Oncol 28:32–35
Sicklick JK, Choti MA (2005) Controversies in the surgical management of cholangiocarcinoma and gallbladder cancer. Semin Oncol 32:S112
Steinert R, Nestler G, Sagynaliev E et al (2006) Laparoscopic cholecystectomy and gallbladder cancer. J Surg Oncol 93:682
Terazawa T, Miyake H, Kurahashi M, Tashiro S (2004) Direct lymphatic spreading route into the liver from the gallbladder: an animal experiment using pig. J Med Invest 51:210
The Southern Surgeons Club (1991) A prospective analysis of 1518 laparoscopic cholecystectomies. N Engl J Med 324:1073
Todoroki T, Iwasaki Y, Orii K et al (1991) Resection combined with intraoperative radiation therapy (IORT) for stage IV (TNM) gallbladder carcinoma. World J Surg 15:357
Tsavaris N, Kosmas C, Gouveris P, Gennatas K, Polyzos A, Mouratidou D et al (2004) Weekly gemcitabine for the treatment of biliary tract and gallbladder cancer. Invest New Drugs 22:193
Tsukada K, Hatakeyama K, Kurosaki I et al (1996) Outcome of radical surgery for carcinoma of the gallbladder according to the TNM stage. Surgery 120:816
Uesaka K, Yasui K, Morimoto T et al (1996) Visualization of routes of lymphatic drainage of the gallbladder with a carbon particle suspension. J Am Coll Surg 183:345
Valle J, Wasan H, Palmer DH et al (2010) Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 362:1273
Varshney S, Butturini G, Gupta R (2002) Incidental carcinoma of the gallbladder. Eur J Surg Oncol 28:4
Wagner AD, Buechner-Steudel P, Moehler M et al (2009) Gemcitabine, oxaliplatin and 5-FU in advanced bile duct and gallbladder carcinoma: two parallel, multicentre phase-II trials. Br J Cancer 101:1846
Wang SJ, Fuller CD, Kim JS et al (2008) Prediction model for estimating the survival benefit of adjuvant radiotherapy for gallbladder cancer. J Clin Oncol 26:2112
Wang SJ, Lemieux A, Kalpathy-Cramer J et al (2011) Nomogram for predicting the benefit of adjuvant chemoradiotherapy for resected gallbladder cancer. J Clin Oncol 29:4627
Weber SM, DeMatteo RP, Fong Y et al (2002) Staging laparoscopy in patients with extrahepatic biliary carcinoma. Analysis of 100 patients. Ann Surg 235:392
Whalen GF, Bird I, Tanski W et al (2001) Laparoscopic cholecystectomy does not demonstrably decrease survival of patients with serendipitously treated gallbladder cancer. J Am Coll Surg 192:189
Wright BE, Lee CC, Iddings DM et al (2007) Management of T2 gallbladder cancer: are practice patterns consistent with national recommendations? Am J Surg 194:820
Yamaguchi K, Chijiiwa K, Ichimiya H et al (1996) Gallbladder carcinoma in the era of laparoscopic cholecystectomy. Arch Surg 131:981
Yamaguchi K, Chijiiwa K, Saiki S et al (1997) Reliability of frozen section diagnosis of gallbladder tumor for detecting carcinoma and depth of its invasion. J Surg Oncol 65:132
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this paper
Cite this paper
Ansari, M.A., Gupta, P., Shukla, V.K. (2015). Current Treatment for Gallbladder Cancer. In: Gandhi, V., Mehta, K., Grover, R., Pathak, S., Aggarwal, B. (eds) Multi-Targeted Approach to Treatment of Cancer. Adis, Cham. https://doi.org/10.1007/978-3-319-12253-3_12
Download citation
DOI: https://doi.org/10.1007/978-3-319-12253-3_12
Published:
Publisher Name: Adis, Cham
Print ISBN: 978-3-319-12252-6
Online ISBN: 978-3-319-12253-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)